Results 101 to 110 of about 65,642 (180)

Cardiotoxicity of BRAF/MEK inhibitors

British Journal of Pharmacology, EarlyView.
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe, Valerie Lohner, Kevin Terre, Thomas Riffelmacher, Roman Pfister   +4 more
wiley   +1 more source

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

World Journal of Surgery, EarlyView.
Matilda Anneback, Priya H. Dedhia, Aimee Di Marco, Els Nieveen van Dijkum, Julie A. Miller, Janice L. Pasieka   +5 more
wiley   +1 more source

Hepatocyte TrkB Acts as a Gatekeeper Against MASH‐Related Liver Fibrosis by Suppressing the TGFβ/CCL2 Axis and Macrophage Infiltration

Cell Proliferation, EarlyView.
Hepatocyte TrkB is identified as a critical gatekeeper against MASH‐related fibrosis. Mechanistically, TrkB inhibits the TGFβ/SMAD3/FOS axis to suppress CCL2 secretion, thereby blocking pathogenic macrophage recruitment and ameliorating liver fibrosis.
Yueying Chen, Jiayi Wei, Shuxuan Li, Kefan Yin, Heming Wang, Yicheng Zhao, Shuqiang Weng, Xizhong Shen, Guangqi Song, Changfeng Zhu, Qunyan Yao, Ling Dong   +11 more
wiley   +1 more source

Targeting the Menin–KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical Translation

European Journal of Haematology, EarlyView.
ABSTRACT Acute leukemias characterized by a shared epigenetic dependency on the menin–KMT2A axis rely on aberrant HOX‐driven transcriptional programs that sustain leukemic self‐renewal and impair differentiation. This dependency is most evident in KMT2A‐rearranged and NPM1‐mutated acute myeloid leukemia (AML), but also extends to other HOX‐dependent ...
Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, Santino Caserta, Francesco Mendicino, Maria Eugenia Alvaro, Caterina Labanca, Eugenio Lucia, Virginia Olivito, Mamdouh Skafi, Nicola Amodio, Fortunato Morabito, Massimo Gentile   +12 more
wiley   +1 more source

Gene structure of the human receptor tyrosine kinase Ron and mutation analysis in lung cancer samples. [PDF]

, 2000
ANGELONI, DEBORA, BREATHNACH R, DANILKOVITCH A, IVANOV SI, JOHNSON BE, LEONARD EJ, LERMAN MI   +6 more
core   +1 more source

Targeted therapy in the treatment of lung cancer in Iceland 2010-2023. [PDF]

Acta Oncol
Tryggvadóttir SÁ, Stefánsson GV, Birgisson H, Gunnarsson Ö, Guðbjartsson T, Harðardóttir H, Hilmarsdóttir B, Barkardóttir RB, Haraldsdottir S.   +8 more
europepmc   +1 more source

Functional siRNA Screen Links Ras/MAPK and Wnt Pathway to EV Secretion in HCT-116 Colorectal Cancer Cells. [PDF]

Diseases
Pätzold SM, Gross JC.
europepmc   +1 more source

Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancer. [PDF]

Cancer Immunol Immunother
Yoshichika R, Mukohara F, Yamada K, Nagasaki J, Watanabe H, Ueda Y, Suzawa K, Shien K, Toyooka S, Ishino T, Togashi Y.   +10 more
europepmc   +1 more source

Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report. [PDF]

Cancer Rep (Hoboken)
Akazawa Y, Sato T, Yagami Y, Kesen Y, Furo T, Watanabe A, Endo J, Nakano M, Kurata H, Matsuo H, Nakahara Y, Sasaki J, Naoki K.   +12 more
europepmc   +1 more source

CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway-altered. [PDF]

Acta Neuropathol Commun
Nagashima H, Takeuchi Y, Jimbo N, Matsuda H, Kimbara S, Tanaka K, Sasayama T.   +6 more
europepmc   +1 more source